Health Affairs on March 15 published three “Policy Options” papers which each focus on key themes highlighted by 12 primers released by journal last year.
Each papers, according to Health Affairs, “provides a clear overview of a distinct and fundamental challenge affecting the prescription market today.”
Below is a brief summary of each paper:
- Vanderbilt University’s Stacie Dusetzina, Henry J. Kaiser Family Foundation’s Juliette Cubanski and Diane Rowland, and University of Washington’s Scott Ramsey examine how policymakers can increase the affordability of specialty drugs by addressing out-of-pocket costs.
- Jonathan Darrow and Aaron Kesselheim, both of the Brigham and Women’s Hospital and Harvard Medical School, delve into the impact competition has had on drug prices, and why new policies are in order.
- Institute of Clinical and Economic Review President Steven Pearson, George Mason University’s Len Nichols and Harvard University’s Amitabh Chandra address how to better align prescription costs with value.
To find out more on Health Affairs, click here.
